INGN-101
N/A
Report date: 2023/02/11 20:38:54
Base Information
Drug NameINGN-101
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntrogenRhône-Poulenc Rorer
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRhône-Poulenc RorerIntrogen
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A